Format

Send to

Choose Destination
See comment in PubMed Commons below
Diabetes Care. 2010 Sep;33(9):2110-2. doi: 10.2337/dc09-0023. Epub 2010 Jun 2.

Incidence and trend of a metabolic syndrome phenotype among Tehranian adolescents: findings from the Tehran Lipid and Glucose Study, 1998-2001 to 2003-2006.

Author information

1
Yazd Diabetes Research Center, Shahid Sadoughi University of Medical Science, Yazd, Iran.

Abstract

OBJECTIVE:

To assess the incidence and trend of the metabolic syndrome phenotype in adolescents from the Tehran Lipid and Glucose Study during 3.6 years of follow-up.

RESEARCH DESIGN AND METHODS:

A total of 932 adolescents, aged 10-19 years, who had complete data and returned for reassessment 3.6 years later were investigated.

RESULTS:

Prevalence of metabolic syndrome at baseline and after 3.6 years was 7.4 and 6.7%, respectively, based on the Adult Treatment Panel (ATP) III definitions; 3.5 and 8.0%, respectively, based on the International Diabetes Federation (IDF) definitions; 4.1 and 9.4%, respectively, based on the American Heart Association (AHA) definitions; and 13.6 and 13.4%, respectively, based on the National Health and Nutrition Examination Survey (NHANES) definitions. Incidence rates were 5.2% (95% CI 3-6) based on ATP III, 6.8% (5-8) based on IDF, 8.3% (6-10) based on AHA, and 8.8% (6-10) based on NHANES definitions.

CONCLUSIONS:

Incidence of metabolic syndrome is high in Tehranian adolescents.

PMID:
20519656
PMCID:
PMC2928373
DOI:
10.2337/dc09-0023
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Support Center